By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Daiichi Suntory Pharma Co., Ltd. 

No.31 Kojimachi MT Building
5-7-2 Kojimachi
Chiyoda-ku  Tokyo  102-8530  Japan
Phone: Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Sepracor, Inc. (SEPR) Announces Resignation of Adrian Adams as President and CEO and Plans for Merger with Daiichi Suntory Pharma Co., Ltd. 2/19/2010 6:23:32 AM
Daiichi Suntory Pharma Co., Ltd. to Move Clot Prevention Drug to Phase 3 10/31/2008 6:30:06 AM
BioMarin Pharmaceutical Inc. (BMRN) Initiates Phase 3 Clinical Trial Of Phenoptin For PKU10/19/2005 5:13:14 PM
Yamanouchi Pharmaceutical Co., Ltd. Terminates Marketing Agreement With Daiichi Suntory Pharma Co., Ltd.10/19/2005 5:12:46 PM
Torre Lazur McCann Creates Consumer Group10/19/2005 5:12:22 PM
Daiichi Suntory Pharma Co., Ltd., BioMarin Pharmaceutical Inc. (BMRN) To Enter Into Licensing Agreement For Phenoptin For The Treatment Of PKU10/19/2005 5:12:19 PM
BioMarin Pharmaceutical Inc. (BMRN) Forms Strategic Partnership With Daiichi Suntory Pharma Co., Ltd. For Phenoptin To Treat Phenylketonuria10/19/2005 5:12:17 PM
Daiichi Pharmaceutical (JPN) Acquires Daiichi Suntory Pharma Co., Ltd. As Wholly Owned Subsidiary For 20 Billion Yen10/19/2005 5:12:11 PM
BioMarin Pharmaceutical Inc. (BMRN) Acquires Rights To Daiichi Suntory Pharma Co., Ltd.'s 6R-BH4 For Treating Vascular Dysfunction In Diabetes And Cardiovascular Disease10/19/2005 5:10:30 PM
Daiichi Suntory Pharma Co., Ltd. To Change Its Name To Daiichi Asubio Pharma10/19/2005 5:09:46 PM
12
//-->